Similar articles for PMID: 30761591

Year	Number of Results
2005	2
2006	3
2007	5
2008	7
2009	6
2010	5
2011	10
2012	6
2013	6
2014	13
2015	19
2016	15
2017	11
2018	24
2019	19
2020	30
2021	17
2022	16
2023	5
2024	0

1

Higher urate in LRRK2 mutation carriers resistant to Parkinson disease.

Bakshi R, Macklin EA, Logan R, Zorlu MM, Xia N, Crotty GF, Zhang E, Chen X, Ascherio A, Schwarzschild MA. Bakshi R, et al. Ann Neurol. 2019 Apr;85(4):593-599. doi: 10.1002/ana.25436. Epub 2019 Mar 3. Ann Neurol. 2019. PMID: 30761591

2

Cerebrospinal fluid biomarkers and clinical features in leucine-rich repeat kinase 2 (LRRK2) mutation carriers.

Vilas D, Shaw LM, Taylor P, Berg D, Brockmann K, Aasly J, Marras C, Pont-Sunyer C, Ríos J, Marek K, Tolosa E. Vilas D, et al. Mov Disord. 2016 Jun;31(6):906-14. doi: 10.1002/mds.26591. Epub 2016 Apr 4. Mov Disord. 2016. PMID: 27041685

3

Association of caffeine and related analytes with resistance to Parkinson disease among LRRK2 mutation carriers: A metabolomic study.

Crotty GF, Maciuca R, Macklin EA, Wang J, Montalban M, Davis SS, Alkabsh JI, Bakshi R, Chen X, Ascherio A, Astarita G, Huntwork-Rodriguez S, Schwarzschild MA. Crotty GF, et al. Neurology. 2020 Dec 15;95(24):e3428-e3437. doi: 10.1212/WNL.0000000000010863. Epub 2020 Sep 30. Neurology. 2020. PMID: 32999056 Free PMC article.

4

Carriers of both GBA and LRRK2 mutations, compared to carriers of either, in Parkinson's disease: Risk estimates and genotype-phenotype correlations.

Yahalom G, Greenbaum L, Israeli-Korn S, Fay-Karmon T, Livneh V, Ruskey JA, Roncière L, Alam A, Gan-Or Z, Hassin-Baer S. Yahalom G, et al. Parkinsonism Relat Disord. 2019 May;62:179-184. doi: 10.1016/j.parkreldis.2018.12.014. Epub 2018 Dec 13. Parkinsonism Relat Disord. 2019. PMID: 30573413

5

Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study.

Simuni T, Uribe L, Cho HR, Caspell-Garcia C, Coffey CS, Siderowf A, Trojanowski JQ, Shaw LM, Seibyl J, Singleton A, Toga AW, Galasko D, Foroud T, Tosun D, Poston K, Weintraub D, Mollenhauer B, Tanner CM, Kieburtz K, Chahine LM, Reimer A, Hutten SJ, Bressman S, Marek K; PPMI Investigators. Simuni T, et al. Lancet Neurol. 2020 Jan;19(1):71-80. doi: 10.1016/S1474-4422(19)30319-9. Epub 2019 Oct 31. Lancet Neurol. 2020. PMID: 31678032 Free PMC article.

6

CSF total and oligomeric α-Synuclein along with TNF-α as risk biomarkers for Parkinson's disease: a study in LRRK2 mutation carriers.

Majbour NK, Aasly JO, Hustad E, Thomas MA, Vaikath NN, Elkum N, van de Berg WDJ, Tokuda T, Mollenhauer B, Berendse HW, El-Agnaf OMA. Majbour NK, et al. Transl Neurodegener. 2020 May 6;9(1):15. doi: 10.1186/s40035-020-00192-4. Transl Neurodegener. 2020. PMID: 32375873 Free PMC article.

7

CSF Nrf2 and HSPA8 in Parkinson's disease patients with and without LRRK2 gene mutations.

Loeffler DA, Smith LM, Coffey MP, Aasly JO, LeWitt PA. Loeffler DA, et al. J Neural Transm (Vienna). 2016 Mar;123(3):179-87. doi: 10.1007/s00702-015-1479-0. Epub 2015 Nov 3. J Neural Transm (Vienna). 2016. PMID: 26526034

8

Motor and non-motor features of Parkinson's disease in LRRK2 G2019S carriers versus matched controls.

Gunzler SA, Riley DE, Chen SG, Tatsuoka CM, Johnson WM, Mieyal JJ, Walter EM, Whitney CM, Feng IJ, Owusu-Dapaah H, Mittal SO, Wilson-Delfosse AL. Gunzler SA, et al. J Neurol Sci. 2018 May 15;388:203-207. doi: 10.1016/j.jns.2018.03.025. Epub 2018 Mar 17. J Neurol Sci. 2018. PMID: 29627023 Free PMC article.

9

Increased peripheral inflammation in asymptomatic leucine-rich repeat kinase 2 mutation carriers.

Dzamko N, Rowe DB, Halliday GM. Dzamko N, et al. Mov Disord. 2016 Jun;31(6):889-97. doi: 10.1002/mds.26529. Epub 2016 Feb 25. Mov Disord. 2016. PMID: 26917005

10

Inflammatory profile in LRRK2-associated prodromal and clinical PD.

Brockmann K, Apel A, Schulte C, Schneiderhan-Marra N, Pont-Sunyer C, Vilas D, Ruiz-Martinez J, Langkamp M, Corvol JC, Cormier F, Knorpp T, Joos TO, Gasser T, Schüle B, Aasly JO, Foroud T, Marti-Masso JF, Brice A, Tolosa E, Marras C, Berg D, Maetzler W. Brockmann K, et al. J Neuroinflammation. 2016 May 24;13(1):122. doi: 10.1186/s12974-016-0588-5. J Neuroinflammation. 2016. PMID: 27220776 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

192 results

Results by year